Axes Health

Foundation date

01/07/2019

Sector

#Professional Services and Consulting

Subsector

  • design, co-create and implement innovative patient access schemes and HTA strategies for biotech companies

  • multi-stakeholder engagement: patient advocacy, early dialogues with competent authorities, mock negotiations, follow up of pricing and reimbursement procedure and access negotiations (conventions)

  • RWE: coordinating the implementation of sustainable disease registries to support appropriate use, new access schemes, pay for performance arrangements and new type of commercial contracting

Upcoming events

Latest news

  • argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis

    Thursday September 21st 2023

  • Galapagos appoints Simon Sturge to its Board of Directors

    Tuesday September 19th 2023

  • 13th Investment for HERAN Partners: Broken String Biosciences (UK)

    Tuesday September 19th 2023